“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Despite near universal availability of nirsevimab, only 35% of eligible children receive nirsevimab for RSV prophylaxis.

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...